Search Results 7761-7770 of 36780 for oral

  1. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

  2. Sharing Mayo Clinic: Tackling a rare autoimmune disease

    "I was continuously on oral chemo drugs and my hemoglobin was so low that I needed 14 blood transfusions over the course of my stay in the hospital," she says.

  3. Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  4. Otolaryngology (ENT)/Head and Neck Surgery - Doctors - Mayo Clinic

    r, Oral and throat cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Salivary gland tumor, Soft palate cancer, Nasal and paranasal tumors ...

  5. Nadia N. Laack, M.D. - Doctors and Medical Staff - Mayo Clinic

    Co-ModeratorOral Scientific Session, American Society for Therapeutic Radiology and Oncology. 2012 - present. MemberProton Coordinating Committee, Department ...

  6. A Phase 3 Study To Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy In Previously Treated Head And Neck Squamous Cell Carcinoma Patients - Mayo Clinic

    The eligible HNSCC primary tumor locations are oropharynx, oral cavity, hypopharynx, and larynx. Documentation of p16 status (positive or negative) by local ...

  7. VE303 for Prevention of Recurrent Clostridioides Difficile Infection - Mayo Clinic

    ... oral or parenteral antibacterial therapy for a non-CDI indication after randomization. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

  8. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

    Receipt of oral anti-rejection or immunomodulatory drugs (including TCZ) within the past 3 months;; Participation in other drug clinical trials ...

  9. A Study to Evaluate Effectiveness and Safety of TD-1473 in Ulcerative Colitis - Mayo Clinic

    If subject is currently receiving oral aminosalicylate (e.g., mesalamine products, balsalazide, or sulfasalazine):; Subject is eligible provided the subject ...

  10. A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

    Oral contraceptive (combined or progesterone only) in females when combined with a chemical or physical barrier method;; Double-barrier method (any ...